Adamas Pharmaceuticals $4,650,000 Securities Settlement

If you purchased or otherwise acquired the publicly traded common stock of Adamas Pharmaceuticals, Inc. between August 8, 2017, and March 4, 2019, you may be eligible to claim a portion of a $4,650,000 settlement from a class action lawsuit.

Adamas Pharmaceuticals, Inc. has agreed to pay $4,650,000 to settle a class action lawsuit for alleged violations of federal securities laws by making false and misleading statements regarding anticipated payer reimbursement for GOCOVRI.

Who can submit a claim?

To be eligible to submit a claim, you must be a person or entity that purchased or otherwise acquired publicly traded Adamas common stock between August 8, 2017, and March 4, 2019, and incurred losses.

This includes anyone who purchased or acquired Adamas stock during this period and held the stock through at least one of the corrective disclosure dates: October 5, 2018, November 2, 2018, or March 5, 2019.

How much can class members get?

The average recovery per eligible share is approximately $0.27 before deductions for court-approved fees, expenses, and costs.

The amount each class member can receive depends on several factors, including the number of shares purchased, the dates of purchase and sale, and the total number of valid claims submitted.

The Net Settlement Fund will be distributed to class members based on a plan of allocation, which considers the price declines observed during the corrective disclosure dates.

The recognized loss amount will be calculated for each purchase or acquisition of Adamas stock during the Settlement Class Period:

• For shares sold before October 5, 2018, the recognized loss amount is $0.00.
• For shares sold between October 5, 2018, and March 4, 2019, the recognized loss amount is the lesser of the amount of per-share price inflation on the date of purchase minus the amount of per-share price inflation on the date of sale, or the purchase price minus the sale price.
• For shares sold between March 5, 2019, and May 31, 2019, the recognized loss amount is the lesser of the amount of per-share price inflation on the date of purchase, the purchase price minus the sale price, or the purchase price minus the “90-Day Lookback Value” on the date of sale.
• For shares held as of the close of trading on May 31, 2019, the recognized loss amount is the lesser of the amount of per-share price inflation on the date of purchase or the purchase price minus the average closing price for Adamas common stock during the 90-Day Lookback Period, which is $6.55.

Is proof required to submit a claim?

Yes, claimants need to provide proof of their transactions and holdings of Adamas stock. This includes:

• Copies of brokerage confirmation slips
• Monthly brokerage account statements
• An authorized statement from your broker containing the transactional and holding information

How to claim an award

To claim an award, you must complete and submit a claim form either online or by mail. You can file a claim online or mail your completed claim form to:

Adamas Securities Litigation

c/o Strategic Claims Services

P.O. Box 230

600 N. Jackson Street, Suite 205

Media, PA 19063

Ensure that your claim form is postmarked or submitted online no later than August 28, 2024.

Claim instructions

Follow these steps to submit your claim:

1. Gather all necessary documentation, including brokerage confirmation slips, monthly brokerage account statements, or an authorized statement from your broker.
2. Complete the claim form with accurate information about your transactions and holdings of Adamas stock.
3. Submit your claim form online at file a claim online or mail it to the address provided above.
4. Ensure your claim form is postmarked or submitted online by August 28, 2024.

How do I get paid?

Once your claim is approved, you will receive your payment via check.

$4,650,000 Settlement Fund

The settlement fund of $4,650,000 will cover several costs, including:

• Taxes on any income earned by the Settlement Fund
• Notice and administration costs
• Litigation expenses awarded by the court
• Attorneys’ fees awarded by the court

The remaining amount, known as the Net Settlement Fund, will be distributed to class members who submit valid claims.

Important dates

• Fairness Hearing: September 27, 2024
• Deadline to File a Claim: August 28, 2024

When is the Adamas Pharmaceuticals payout date?

The awards will be paid after the court grants final approval of the settlement and all claims have been processed.

What happens next?

Next, the court will hold a Fairness Hearing on September 27, 2024, to determine whether to approve the settlement. If approved, the Claims Administrator will process the claims and distribute the Net Settlement Fund to eligible class members.